Compliance Program For EU Annex 1 Container Closure Requirements


The new EU GMP Annex 1 contains new requirements for the container closure integrity (CCI) of sterile pharmaceutical products. These requirements will trigger new industry best practices in the area of CCI. Discover a program created to comply with Annex 1 CCI requirements, focusing on vials, syringes, and cartridges. The program is designed as a holistic, science-based approach generating robust statistical data throughout the product life cycle.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online